Celcuity (CELC) Retained Earnings (2016 - 2025)
Celcuity (CELC) reported Retained Earnings of -$448.9 million for Q4 2025, down 65.12% on a YoY basis from -$1.3 billion in Q4 2024, and down 12.81% quarter-over-quarter from -$397.9 million in Q3 2025.
Celcuity (CELC) Retained Earnings (2016 - 2025) Analysis & Trends
Celcuity has reported Retained Earnings for 10 years, with the latest figure at -$448.9 million in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings fell 65.12% year-over-year to -$448.9 million; the trailing twelve-month figure through Dec 2025 stood at -$448.9 million (down 65.12% YoY), and the FY2025 full-year result was -$448.9 million, down 65.12% from the prior year.
- Retained Earnings for Q4 2025 stood at -$448.9 million, down from -$397.9 million in the prior quarter.
- The five-year high for Retained Earnings was -$29.1 million in Q1 2021, with the low at -$448.9 million in Q4 2025.
- Historically, Retained Earnings has averaged -$171.6 million across 5 years, with a median of -$132.0 million in 2023.
- Annual changes were most pronounced in 2021 — Retained Earnings slumped 52.47% — and 2022, when it plunged 119.35%.
- Celcuity's Retained Earnings stood at -$55.9 million in 2021, then tumbled by 72.18% to -$96.3 million in 2022, then slumped by 66.23% to -$160.1 million in 2023, then slumped by 69.83% to -$271.9 million in 2024, then tumbled by 65.12% to -$448.9 million in 2025.
- The last three Retained Earnings figures came in at -$448.9 million (Q4 2025), -$397.9 million (Q3 2025), and -$354.1 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -838.07 Mn |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | -448.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -448.90 Mn |
| Sep 30, 2025 | -397.92 Mn |
| Jun 30, 2025 | -354.12 Mn |
| Mar 31, 2025 | -308.85 Mn |
| Dec 31, 2024 | -271.86 Mn |
| Sep 30, 2024 | -235.20 Mn |
| Jun 30, 2024 | -205.41 Mn |
| Mar 31, 2024 | -181.69 Mn |
| Dec 31, 2023 | -160.08 Mn |
| Sep 30, 2023 | -141.23 Mn |
| Jun 30, 2023 | -122.82 Mn |
| Mar 31, 2023 | -108.24 Mn |
| Dec 31, 2022 | -96.30 Mn |
| Sep 30, 2022 | -84.72 Mn |
| Jun 30, 2022 | -73.82 Mn |
| Mar 31, 2022 | -63.86 Mn |
| Dec 31, 2021 | -55.93 Mn |
| Sep 30, 2021 | -49.17 Mn |
| Jun 30, 2021 | -43.15 Mn |
| Mar 31, 2021 | -29.11 Mn |